Background: The interaction between the host and microbiota is influenced by host circadian rhythm. However, it is unknown what the changes of gut microbiota and metabolites.Methods: We conducted a cross-sectional study (n=72) in which participants’ fecal DNA was detected by macrogenomic sequencing analysis. The feces, urine and blood were analyzed by widely targeted metabolomics analysis.Results: Pearson correlation analysis showed that most of the clinical symptoms of people with circadian rhythm disorders were moderately positively correlated with gastrointestinal symptoms. By distilling the results of multinomic analysis, we reported a variety of different species (19 species in the gut) and metabolites. In our results, the correlation of multiomics is mostly concentrated in Lachnospiraceae bacterium and Streptococcus mitis oralis pneumoniae. Bile acid-related metabolites are the most significant metabolites associated with these species.Discussion: Our study demonstrates the severity of clinical manifestations caused by circadian rhythm disorder is closely related to microbiota and metabolism. In the future, personalized interventions targeting specific microbial species or metabolites may help alleviate the physical and psychological discomfort induced by circadian rhythm disturbances.
Inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and ulcerative colitis (UC). The accurate classification of IBD from colonoscopy images is critical for diagnosis and treatment. However, the lack of labeled data poses a major challenge for developing deep learning-based IBD classification approaches. Recently, pseudo-labeling-based semi-supervised learning methods offer a promising solution in leveraging both labeled and unlabeled data to improve classification performance. Nevertheless, due to significant intra-class variability and the subtle inter-class differences in IBD colonoscopy images, pseudo-labels are often inaccurate, which results in confirmation bias and suboptimal performance. To address this challenge, a Subclass-Aware Contrastive Semi-Supervised Learning method, referred to as SACSSL, is proposed for accurate IBD classification by integrating a subclass-aware contrastive module into a pseudo-labeling-based semi-supervised framework, e.g., FixMatch. Specifically, unlabeled samples are first partitioned into confident and uncertain samples according to the confidence of pseudo-labels. An instance-level contrastive loss is then applied to uncertain samples, aiming to mitigate confirmation bias. Furthermore, intra-class heterogeneity is captured by introducing a set of prototypes for each subclass and assigning confident samples to these prototypes to form fine-grained subclasses, and supervised contrastive loss is applied to promote intra-subclass clustering, thereby enhancing inter-class separability while preserving intra-class diversity. Our method is evaluated on two datasets, i.e., an in-house collected Daping dataset for IBD classification and a publicly available LIMUC dataset for UC severity grading. On both datasets, our method achieves state-of-the-art performance under the semi-supervised setting. Specifically, with only 20% labeled data, the proposed method reaches an overall accuracy of 93.2% and an F1-score of 80.1% on the Daping dataset, which is close to the fully supervised upper bound (94.0% accuracy and 80.8% F1-score), and it achieves an overall accuracy of 76.4% and an F1-score of 68.9% on the LIMUC dataset. Comprehensive experimental results demonstrate the effectiveness of our method for semi-supervised colonoscopy image classification.